Wednesday 5th July
Cambridge, UK and Online

Milner Therapeutics Symposium 2023

Symposium Overview

Join us for our 2023 Therapeutics Symposium on Wednesday 5th July, which will once again take place as a hybrid event. A fantastic line-up of speakers will present live at West Road Concert Hall in Cambridge, and talks will be streamed to an online platform.

Our Annual Symposium is an opportunity for scientists from academia and industry to discuss the latest academic and pre-clinical research and how it could be applied in the pharma and biotech industry to develop new treatments. It is our key networking event for Milner Therapeutics Institute partner organisations.

If you have any questions about the Symposium, please email



Information for Attendees

The Milner Therapeutics Symposium 2023 will be held as a hybrid event. The in-person event will be held at West Road Concert Hall in Cambridge, and sessions were also live-streamed to an online platform. Registration is free to academics and Milner affiliated companies only.


Oncology   ·   CNS therapeutics   ·   Epigenetics ·   Emerging technologies   ·   Disease-relevant models in target discovery


Serena  Nik-Zainal (Early Cancer Institute, University of Cambridge), Wolf Reik (Altos Labs), Karen Duff (​UK Dementia Research Institute at University College London), Allan Bradley (Cambridge Institute of Therapeutic Immunology & Infectious Disease and Kymab), Cigall Kadoch (Dana Farber Cancer Institute and Harvard Medical School) Mene Pangalos (AstraZeneca), Manav Pathania (Department of Oncology and Milner Therapeutics Institute), Debora Lucarelli (Enhanc3d Genomics) and David Walter and Douglas Ross-Thriepland (AstraZeneca Cancer Research Horizons Functional Genomics Centre).

Read more about our speakers further down this page.


We are now inviting poster abstracts from academia and industry, to be presented in person and/or digitally as part of our hybrid Symposium! The posters will be on display throughout the day, and are an integral part of our lunch, coffee and networking sessions. The deadline for abstract submission is Monday, 5th June.
Submit an abstract here »

Affiliated Company Overviews

Milner affiliated companies are invited to submit a short company overview, for inclusion in our symposium booklet. The deadline for submissions is 1st May.
Submit your overview here » 


Meet the Consortium Session

Registered attendees are now able to request a short meeting with Pharma companies in the Milner Therapeutics Consortium during the morning of the Symposium! These non-confidential discussions provide introductions between academics and affiliated companies and our pharma partners, and are aimed at identifying collaborative opportunities. The deadline is Monday, 5th June. Request a meeting here »

Accommodation in Cambridge

If you’re travelling from outside Cambridge and need to book accommodation, a selection of Cambridge hotels is listed below. We recommend booking early for best prices and availability.

For a uniquely Cambridge experience, you can also book accommodation at a University of Cambridge College. A wide variety of rooms is available at a range of prices. Please note that some College rooms do not include breakfast.

If you have questions about accommodation, please email

Plenary Speakers


“Targeting the DNA damage response”

Serena Nik-Zainal

Early Cancer Institute
University of Cambridge

“Targeting the DNA damage response”

Wolf Reik

 Altos Labs

“Targeting the DNA damage response”

Karen Duff

UK Dementia Research Institute at University College London

“Targeting the DNA damage response”

Allan Bradley

Cambridge Institute of Therapeutic Immunology & Infectious Disease
and Kymab


“Targeting the DNA damage response”

Cigall Kadoch

Dana Farber Cancer Institute
and Harvard Medical School

“Targeting the DNA damage response”

Mene Pangalos


Spotlight Talks: Research and Entrepreneurship at the Milner Therapeutics Institute

“Targeting the DNA damage response”

Debora Lucarelli

Debora Lucarelli
Enhanc3d Genomics

“No Cancer Cell is an Island: why the microenvironment matters during pancreatic cancer progression and treatment”

Manav Pathania

Dept of Oncology and Milner Therapeutics Institute
University of Cambridge

Mo Zhao

Douglas Ross-Thriepland

Douglas Ross-Thriepland
AstraZeneca-Cancer Research Horizons
Functional Genomics Centre

Mo Zhao

David Walter

David Walter
AstraZeneca-Cancer Research Horizons
Functional Genomics Centre

Countdown to #MilnerSymp23








With thanks to our Symposium sponsors


Silver Sponsor:

Bronze Sponsors: